Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06693934Recruiting
Open-label trial (4 arms). Primary endpoint: Incidence of prediabetes or diabetes in the high and low risk progressor groups at 2 years. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06693934.